Notch activation leads to growth inhibition, differentiation and cell death in AML, and it was specifically silenced in the CD34+/CD38- stem/multipotential progenitor populations of AML patients, when compared to normal CD34+ stem cells [144]. Here, CD38 is linked to acute myeloid leukemia.